These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 27287852

  • 1. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
    Otake K, Sakurai Y, Nishida H, Fukui H, Tagawa Y, Yamasaki H, Karashima M, Otsuka K, Inatomi N.
    Adv Ther; 2016 Jul; 33(7):1140-57. PubMed ID: 27287852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological characteristics and clinical efficacies of a novel potassium-competitive acid blocker, vonoprazan fumarate].
    Matsukawa J, Inatomi N, Nishida H, Tsukimi Y.
    Nihon Yakurigaku Zasshi; 2018 Jul; 152(3):104-110. PubMed ID: 30185727
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.
    Jung YS, Kim EH, Park CH.
    Aliment Pharmacol Ther; 2017 Jul; 46(2):106-114. PubMed ID: 28497487
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J, Hosaka H, Kuribayashi S, Moriyasu S, Hisada Y, Okubo H, Watanabe K, Imbe K, Nagata N, Kojima Y, Yokoi C, Uemura N, Shimoyama Y, Kawamura O, Yamada M, Kusano M.
    Digestion; 2020 Jul; 101(2):174-183. PubMed ID: 30897577
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.
    Oshima T, Arai E, Taki M, Kondo T, Tomita T, Fukui H, Watari J, Miwa H.
    Aliment Pharmacol Ther; 2019 Jan; 49(2):140-146. PubMed ID: 30589965
    [Abstract] [Full Text] [Related]

  • 16. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.
    Oshima T, Miwa H.
    J Neurogastroenterol Motil; 2018 Jul 30; 24(3):334-344. PubMed ID: 29739175
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
    Sakurai Y, Shiino M, Okamoto H, Nishimura A, Nakamura K, Hasegawa S.
    Adv Ther; 2016 Sep 30; 33(9):1519-35. PubMed ID: 27432383
    [Abstract] [Full Text] [Related]

  • 18. [Vonoprazan: a novel potassium-competitive acid blocker].
    Sugano K.
    Nihon Rinsho; 2015 Jul 30; 73(7):1163-8. PubMed ID: 26165074
    [Abstract] [Full Text] [Related]

  • 19. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M, Nakahara K, Iwakura N, Hasegawa T, Oyama M, Inoue A, Ishizu H, Satoh H, Fujiwara Y.
    Digestion; 2017 Jul 30; 95(4):281-287. PubMed ID: 28501868
    [Abstract] [Full Text] [Related]

  • 20. Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.
    Matsukawa J, Kogame A, Tagawa Y, Inatomi N.
    Dig Dis Sci; 2016 Jul 30; 61(7):1888-94. PubMed ID: 26961787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.